Clinical Trial

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-10-02; most recent amendment 2026-07-16.
Status change: Recruiting → Active, Not Recruiting 2026-07-16
Status change: Not Yet Recruiting → Recruiting 2025-11-20
Trial Details
NCT Number NCT07213648
Lead Sponsor University of Virginia
Collaborators: National Institute of Nursing Research (NINR)
Conditions Huntington Disease, Parkinson Disease
Enrollment 136 participants
Start Date 2025-11-20
Primary Completion 2026-08 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-20